Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2017

Feb 21, 2017

30016_dirs_2017-02-21_cce660d1-4951-414d-bcf1-5c17f8dc9748.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-02-16

Reporting Person: END WILLIAM T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-16 Common Stock S 5000 $141.7068 Disposed 50256 Direct

Footnotes

F1: Represents the weighted average sales price of the shares sold ranging from a low of $141.6166 to a high of $141.8165 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.